Ilona Michałowska

Ilona Michałowska

Auto-generated profile, based on publicly available information

Ilona Michałowska

Department of Hypertension, and Department of Radiology Institute of Cardiology, 04-628 Warsaw, Poland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Endocrine Practice
Verified
Journal Article
Closed access
IMIlona Michałowska
Ilona Michałowska
JĆJarosław Ćwikła
Jarosław Ćwikła
WMWojciech Michalski
Wojciech Michalski
LWLucjan Wyrwicz
Lucjan Wyrwicz
APAleksander Prejbisz
Aleksander Prejbisz
MPMariola Pęczkowska
Mariola Pęczkowska

Verified
Journal Article
Open access
PDF file
AKAgnieszka Kolasińska-Ćwikla
Agnieszka Kolasińska-Ćwikla
MPMariola Pęczkowska
Mariola Pęczkowska
JĆJarosław Ćwikła
Jarosław Ćwikła
IMIlona Michałowska
Ilona Michałowska
JPJakub M. Pałucki
Jakub M. Pałucki
AJAndrzej Januszewicz
Andrzej Januszewicz
Paragangliomas and pheochromytomas (PPGLs) exhibit variable malignancy, advanced/hormonally active/progressive need therapy. PRRT (Peptide Receptor Radionuclide Therapy) could be an option for these patients. To evaluate the effectiveness of PRRT (90Y DOTATATE), based on overall survival (OS) and progression-free survival (PFS), in patients with PPGLs, related to SDHx gene mutation, we conducted a prospective open-label, single-center, phase II study. Thirteen patients were observed, eight PGL1 and five PGL4, all with advanced, non-resectable tumors, and eight had metastases. All were treated with 90Y DOTATATE. Efficacy was based on OS and PFS, and radiological response was based on RECIST. Hormonal activity was evaluated using serum-fractionated free catecholamines. Eight subjects had a clinical response, three were stable, and two exhibited disease progression. Among four patients with hormonally-active PPGLs, three showed a reduction and one showed normalization. OS for all was 68.0 months; PFS was 35.0 months. OS in PGL4 = 25.0 vs. N.R. (not reached) in PGL1. PFS in PGL4 = 12.0 vs. N.R. in PGL1. A difference was seen in the OS and PFS in patients who did not respond clinically, compared to those who did, OS = 22.0 vs. N.R. PFS = 7.0 vs. N.R. A difference in the OS and PFS was noted in patients with liver and bone involvement compared to those without. PRRT is an effective therapy in selected population of patients with SDHx, in those with locally-advanced, non-resectable tumors. Furthermore, it is effective regardless of the secretory status.

13 December 2018 in Polish Journal of Radiology
Verified
Journal Article
Open access
IMIlona Michałowska
Ilona Michałowska
PSPiotr Szymański
Piotr Szymański
PKPaweł Kwiatek
Paweł Kwiatek
MSMichał Spałek
Michał Spałek
MFMariusz Furmanek
Mariusz Furmanek
MLMagdalena Lipczyńska
Magdalena Lipczyńska
Purpose: Caseous calcification is a relatively uncommon variant of calcification of the mitral annulus. The purpose of the study was to assess characteristic radiological features of caseous calcification of the mitral annulus (CCMA) using computed tomography (CT) and compare the usefulness of CT and transthoracic echocardiogram (TTE) in a diagnosis of CCMA.Material and methods: Seventeen patients with CCMA, who underwent TTE and CT, were analysed. The following features of CCMA were evaluated: location, size, attenuation, enhancement after contrast administration, and margins.Results: In all cases TTE visualised an echo-dense structure with an irregular appearance involving the mitral valve annulus. In five cases the acoustic shadowing artefact was visible, and in four cases the mass contained central areas of echolucency. Eleven patients had valve disease. On CT CCMA appeared as a round mass in one case, in 10 cases as an oval mass, and in six patients it had a semilunar shape. In all cases on unenhanced CT, CCMA appeared as a hyperdense mass. On enhanced CT, CCMA in 10 cases (58.8%) had a hypodense centre, and in 7seven (41.2%) it had a hyperdense centre without enhancement after contrast administration. A hyperdense rim was observed in all cases except one patient.Conclusions: In cases of the atypical appearance of CCMA on TTE, CT can lead to a definitive diagnosis. The combination of unenhanced CT and after IV contrast administration scans allows for recognition and distinction of CCMA from other pathologies, while TTE allows for assessment of additional valve dysfunction.

28 June 2018 in Cardiology Journal
Verified
Journal Article
Open access
PDF file
IMIlona M. Michałowska
Ilona M. Michałowska
AKAgnieszka Kolasinska-Ćwikla
Agnieszka Kolasinska-Ćwikla
JĆJarosław Ćwikła
Jarosław Ćwikła
DZDariusz Zakrzewski
Dariusz Zakrzewski
MPMariola Pęczkowska
Mariola Pęczkowska